跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 228 条关于
“Vβ6”
全部
228
临床试验
214
药物
4
机构
0
资讯
10
2个月前
Marengo Secures ESMO 2026 Oral Presentation for Phase 2 Invikafusp Alfa Data in PD-1–Resistant Solid Tumors, Appoints KEYTRUDA Development Leader Eric Rubin to Scientific Advisory Board
去年
Invikafusp Alfa Demonstrates Promising Activity in Immune Checkpoint Inhibitor-Resistant Solid Tumors
去年
Marengo's Invikafusp Alfa Shows Promise in Anti-PD-1 Resistant Solid Tumors
5个月前
Marengo Therapeutics Reports Confirmed Complete Responses in Phase 2 Trial of Invikafusp Alfa Plus TRODELVY for Metastatic Breast Cancer
去年
Invikafusp Alfa Shows Promise in PD-1 Resistant Solid Tumors
去年
Marengo Therapeutics Strengthens Leadership with Pfizer Veteran Dolsten and Oncology Expert Tabernero
2年前
Marengo Therapeutics and Gilead Sciences Collaborate to Evaluate Combination Therapy for Metastatic Breast Cancers
11个月前
Invikafusp Alfa Shows Promise in Checkpoint Inhibitor-Resistant Solid Tumors with High Disease Control Rates
去年
HER2 and αVβ6 Integrin Crosstalk Drives Breast Cancer Invasion and Trastuzumab Resistance
去年
Alphamab Oncology Receives IND Approval for First-in-Class Bispecific ADC JSKN022 Targeting PD-L1 and Integrin αvβ6